Gillead had signed partnership agreements with Lily to blosterd remdesivir effectiness with combo drugs - which is very much lacking, also surppose to be talking with Austrlaina SPL for same reason.
I read a statement - on Gillead website earlier on the suggest remdesivir wasn't all that effect, unless taken very early on ..and no effect on moderate to serve case...yet gets approval- what a corrupt world we live in?!
other companies struggle to get approval for treatment that actuall work.
Big Pharma at work
TYPE A OUTCOME AND NOVARTIS PARTNERSHIP, page-99
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.5¢ |
Change
0.005(0.54%) |
Mkt cap ! $1.056B | |||
| Open | High | Low | Value | Volume |
| 93.0¢ | 93.5¢ | 91.5¢ | $1.473M | 1.596M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 32370 | 92.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 93.0¢ | 60258 | 5 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |